US2023338584A1PendingUtilityA1

Novel peptide-based cancer imaging agents

65
Assignee: OHIO STATE INNOVATION FOUNDATIONPriority: Aug 19, 2017Filed: Aug 22, 2022Published: Oct 26, 2023
Est. expiryAug 19, 2037(~11.1 yrs left)· nominal 20-yr term from priority
Inventors:Michael F. TweedleShankaran KothandaramanChadwick Lewis WrightLi Gong
A61K 49/0043A61K 47/64A61P 35/00A61K 49/0032C07K 7/06A61K 38/00A61K 45/06A61K 49/0052A61K 49/0056A61K 47/54A61K 33/243A61P 31/20C07K 16/00C07K 7/08
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are compositions and methods relating to novel tumor targeting peptides.

Claims

exact text as granted — not AI-modified
1 . An isolated peptide that targets a tumor cell, wherein said peptide comprises the amino acid sequence of TLPNSNHIKQGL (SEQ ID NO: 1), TSPLNIHNGQKL (SEQ ID NO: 2), LNKQTHGLIPNS (SEQ ID NO: 3), NQHSKNTLLIGP (SEQ ID NO: 4), LKQGNHINLPS (SEQ ID NO: 5), YSPLNIHNGQKL (SEQ ID NO: 6), LPNSNHIKQGL (SEQ ID NO: 7), YLPNSNHIKQGL (SEQ ID NO: 8), or FLPNSNHIKQGL (SEQ ID NO: 9). 
     
     
         2 - 49 . (canceled)

Join the waitlist — get patent alerts

Track US2023338584A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.